#CTAD26: Biogen’s tau drug slows Alzheimer’s more after nearly two years
BOSTON — The benefits of Biogen's experimental Alzheimer's drug seem to get better with time. Over the summer, Biogen reported that the lowest dose of its gene-silencing therapy diranersen slowed the disease by ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.